About us
As individuals we have contributed technical and regulatory expertise to the regulation of medicines in the EU, but our best work has been in partnership. Together we will develop and challenge your understanding of methods for drug development, standards for authorization and optimal use of regulatory procedures.
We have worked together for many years at the European Medicines Agency, predominately through Committee for Medicinal Products for Human Use (CHMP) and its Scientific Advice Working Party (SAWP). We have worked at the interface of science and regulation developing standards for CHMP Scientific Opinions, solutions for the design of challenging drug development programmes; new regulatory guidance and novel regulatory pathways and procedures.
